Glaukos
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Glaukos and other ETFs, options, and stocks.About GKOS
Glaukos Corp. is an ophthalmic medical technology and pharmaceutical company, which focuses on novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It engages in development and commercialization of therapies across several end markets within ophthalmology.
GKOS Key Statistics
Stock Snapshot
As of today, Glaukos(GKOS) shares are valued at $119.07. The company's market cap stands at 6.84B, with a P/E ratio of -76.77.
On 2026-01-30, Glaukos(GKOS) stock traded between a low of $118.67 and a high of $123.64. Shares are currently priced at $119.07, which is +0.3% above the low and -3.7% below the high.
Glaukos(GKOS) shares are trading with a volume of 737.66K, against a daily average of 1.07M.
In the last year, Glaukos(GKOS) shares hit a 52-week high of $161.78 and a 52-week low of $73.16.
In the last year, Glaukos(GKOS) shares hit a 52-week high of $161.78 and a 52-week low of $73.16.
GKOS News
Wells Fargo notes that Glaukos (GKOS) has announced FDA approval of its repeat dosing label for iDose, in line with the firm’s expectations. Label appears broad...
Advertisement Why Glaukos Is Back on Investors’ Radar Glaukos (GKOS) has attracted fresh attention after issuing preliminary fourth quarter and full year 2025...
Glaukos Corporation recently reaffirmed its 2026 net sales guidance of US$600 million to US$620 million and released preliminary 2025 figures pointing to strong...
Analyst ratings
88%
of 16 ratingsPeople also own
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.